ORIC Pharmaceuticals, Inc.
ORIC
$13.87
$0.151.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.13% | -19.14% | 15.98% | 5.73% | -13.74% |
| Total Depreciation and Amortization | -14.84% | -10.60% | 5.26% | 6.67% | 13.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.38% | 24.47% | 69.18% | 62.19% | 121.59% |
| Change in Net Operating Assets | 387.31% | 52.85% | -62.01% | -10.30% | -123.17% |
| Cash from Operations | -2.47% | 0.29% | 19.86% | 12.80% | -20.36% |
| Capital Expenditure | -465.08% | 99.48% | -3.65% | 91.63% | 81.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 115.90% | -178.70% | -59.86% | -570.45% | -512.97% |
| Cash from Investing | 115.42% | -180.07% | -60.18% | -579.13% | -520.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.39% | 24,458.50% | 160.87% | 88,147.62% | 16,409.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -310.33% | -- | -- | -- |
| Cash from Financing | -99.38% | 555,718.18% | 160.87% | 86,765.87% | 16,358.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -171.29% | 206.50% | -126.35% | -367.70% | 506.34% |